Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, May 21, 2019 at 04.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for the year ended March 31, 2019. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, Vice-President- Finance and Dr. Caesar Sengupta, Vice-President- Operations, represented the Company.